European Non-invasive Trisomy Evaluation (EU-NITE Study): Evaluation of a targeted analysis of cell free fetal DNA in maternal blood for prenatal diagnosis of fetal trisomies.

European Non-invasive Trisomy Evaluation (EU-NITE Study): Evaluation of a targeted analysis of cell free fetal DNA in maternal blood for prenatal diagnosis of fetal trisomies. - EU-NITE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36065

Enrollment

630

Registered

2011-05-27

Start date

2011-06-01

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chromosomal aberration trisomy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Singleton pregnancy with gestational age between 9 and 23 weeks, informed consent.

Exclusion criteria

Exclusion criteria: Invasive procedure performed prior to taking the blood sample, history or active significant malignancy in the mother requiring major surgery or systemic chemotherapy, language restriction with failure to understand the study information.

Design outcomes

Primary

Measure	Time frame
detection rate of trisomies with Tandem SNPs	—

Countries

Netherlands

Outcome results